Lupin has acquired the Netherlands-based firm, Nanomi. Lupin commented that the acquisition marked a foray into the technologically-intensive complex injectables sphere, adding that with the use of Nanomi's proprietary technology platform, Lupin would be able to make significant inroads into the niche area of complex injectables.
Nanomi was founded in 2004 and is located in Oldenzaal. It is a drug delivery company that develops pharmaceutical products based on nano- and microparticles. Nanomi targets business-to-business partnerships with pharmaceutical and biotech companies.